← All organizations

Alcyone Lifesciences, Inc.

For profitWebsite ↗

Also known as: Alcyone Lifesciences, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Nov 4, 2021

Timeline

2010s

Jan 1, 2010
Alcyone Lifesciences, Inc.— Founded

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

aav9 carrying the ighmbp2 gene

Phase 1 (1 own, 0 via acquisition)

Tasadenoturev

Indications

Studied for

Glioma

Recent trials (2)

NCT05152823CollaboratorPhase 1/Phase 2Nov 4, 2021
NCT03178032CollaboratorPhase 1May 30, 2017

Details

Founded: Lowell, MA, US Jan 1, 2010
Last known activity: Nov 4, 2021